Iradimed (IRMD) Cash from Financing Activities (2013 - 2026)
Iradimed (IRMD) posted quarterly Cash from Financing Activities of -$2.8 million for Q2 2026, down 23.66% year-over-year from -$3.7 million in Q2 2025, and down 7.1% on a QoQ basis from -$2.6 million in Q1 2026.
Iradimed (IRMD) Cash from Financing Activities (2013 - 2026) Analysis & Trends
Iradimed has reported Cash from Financing Activities for 14 years, with the latest figure at -$2.8 million in Q2 2026.
- Cash from Financing Activities for Q2 2026 came in at -$2.8 million, down 23.66% year-over-year; the trailing twelve-month figure through Jun 2026 was -$18.5 million (down 108.13% YoY), and the FY2025 annual result was -$17.6 million, down 22.77% from the prior year.
- Cash from Financing Activities declined to -$2.8 million in Q2 2026, from -$2.6 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $52341.0 in Q3 2022 and troughed at -$13.3 million in Q1 2023.
- A 5-year average of -$3.5 million and a median of -$2.2 million in 2025 frame the typical range for Cash from Financing Activities.
- The widest annual swing landed in 2022, when Cash from Financing Activities sank 34536.13%; it then surged 71.67% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$198457.0 in 2022, then slumped by 32.32% to -$262590.0 in 2023, then slumped by 820.64% to -$2.4 million in 2024, then plunged by 349.78% to -$10.9 million in 2025, then jumped by 74.33% to -$2.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$2.8 million in Q2 2026, -$2.6 million in Q1 2026, and -$10.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Iradimed | 1.11 Bn | 1.06 Bn | 15.16 Mn | -2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.79 Mn |
| Jun 30, 2026 | -2.79 Mn |
| Mar 31, 2026 | -2.61 Mn |
| Mar 31, 2026 | -2.61 Mn |
| Dec 31, 2025 | -10.87 Mn |
| Dec 31, 2025 | -10.87 Mn |
| Sep 30, 2025 | -2.19 Mn |
| Sep 30, 2025 | -2.19 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Jun 30, 2025 | -2.26 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Mar 31, 2025 | -2.28 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Dec 31, 2024 | -2.42 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Sep 30, 2024 | -1.92 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -1.96 Mn |
| Mar 31, 2024 | -8.04 Mn |
| Mar 31, 2024 | -8.04 Mn |